BOSTON, March 04, 2019 /PRNewswire-PRWeb/ -- Concerto HealthAI, a technology leader in definitive Real World Data (RWD) and Artificial Intelligence solutions for precision health in oncology and other key therapeutic areas, announces the addition of three senior strategic leaders with extensive research and industry experience in AI and deep learning applications. Smita Agrawal, Ph.D., Shesh Thiruvenkadam, Ph.D., and Vivek Vaidya will advance new validated AI technology models and solutions within Concerto HealthAI's eurekaHealthTM platform and further enable impactful Real World Data and Real World Evidence solutions.
"These hires reflect our commitment to bringing together the best minds in AI technology and data science to accelerate the future of health care," said Jeff Elton, Ph.D., CEO of Concerto HealthAI. "I am thrilled to welcome Smita, Shesh and Vivek as their cutting-edge research and knowledge of applications of AI in health care will help us speed the pace of innovation and better outcomes for patients."
Smita Agrawal joins as senior director of product management and will lead eurekaHealth's AI model definition and model validation, drive new feature development and work with Natural Language Processing (NLP) teams on extraction processes. She brings over 17 years of experience applying analytical methods to solving problems in oncology, neuroscience, immunology, genetics and stem cell biology. Smita has 11 published articles in peer-reviewed journals and 2 patents to her name. Previously, Smita worked at Genentech and Strand Life Sciences. She has a B.Tech in Chemical Engineering from IIT Kanpur, India. Her Ph.D. is in Chemical Engineering from the University of California at Berkeley with post-doctoral training in Human Genetics at the University of Minnesota.
As a senior principal scientist, Shesh Thiruvenkadam will be responsible for designing new and differentiated AI models within eurekaHealth that bring more impactful applications to life sciences companies. Shesh has more than 20 years of experience building predictive algorithms and image analysis tools for healthcare. His work has changed how the industry uses predictive models for disease risk and critical events based on RWD, algorithms to simplify workflows and deep learning techniques to aid in image analysis. Shesh holds 10 patents with 21 more pending and he has contributed to 25 peer reviewed, published articles. Previously, Shesh was a senior research scientist at GE Global Research and a principal technology consultant and head of data science at Attune Technologies. He has a B.S. and M.S. in Mathematics from the University of Madras, India, a Ph.D. in Applied Mathematics from the University of Florida and was a post-doctoral scholar at UCLA.
Vivek Vaidya is a senior principal scientist at Concerto HealthAI whose work enables powerful AI modeling and analytics solutions. In 2018, Silicon India magazine named him one of India's top 10 data scientists. At Concerto HealthAI, Vivek has been instrumental in driving four critical AI models (stage, survival, neutropenia and metastatic status) from clinical validation to industry application. Previously, he worked at GE Global Research where he led teams in building a deep learning accelerator platform, recently released as Edison AI. Vivek has filed 20 patents on a variety of technologies, including interactive representation transfer of deep learning ontologies, MRI scanner automation and distributed solutions for deep learning. He also has over 30 conference and journal publications on AI technologies and applications. Vivek has a B.S. in Computer Science from Washington State University.
About Concerto HealthAI Concerto HealthAI is a technology leader in Definitive Real-world Data (RWD) and AI solutions for precision health. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is to revolutionize clinical and outcomes research to accelerate the insights and outcomes benefiting patient treatment. Concerto HealthAI is a SymphonyAI company. eurekaHealth is a trademark of Concerto HealthAI. For more information, visit us at http://www.concertohealthai.com.
SOURCE Concerto HealthAI
Advertisement
"These hires reflect our commitment to bringing together the best minds in AI technology and data science to accelerate the future of health care," said Jeff Elton, Ph.D., CEO of Concerto HealthAI. "I am thrilled to welcome Smita, Shesh and Vivek as their cutting-edge research and knowledge of applications of AI in health care will help us speed the pace of innovation and better outcomes for patients."
Advertisement
Smita Agrawal joins as senior director of product management and will lead eurekaHealth's AI model definition and model validation, drive new feature development and work with Natural Language Processing (NLP) teams on extraction processes. She brings over 17 years of experience applying analytical methods to solving problems in oncology, neuroscience, immunology, genetics and stem cell biology. Smita has 11 published articles in peer-reviewed journals and 2 patents to her name. Previously, Smita worked at Genentech and Strand Life Sciences. She has a B.Tech in Chemical Engineering from IIT Kanpur, India. Her Ph.D. is in Chemical Engineering from the University of California at Berkeley with post-doctoral training in Human Genetics at the University of Minnesota.
As a senior principal scientist, Shesh Thiruvenkadam will be responsible for designing new and differentiated AI models within eurekaHealth that bring more impactful applications to life sciences companies. Shesh has more than 20 years of experience building predictive algorithms and image analysis tools for healthcare. His work has changed how the industry uses predictive models for disease risk and critical events based on RWD, algorithms to simplify workflows and deep learning techniques to aid in image analysis. Shesh holds 10 patents with 21 more pending and he has contributed to 25 peer reviewed, published articles. Previously, Shesh was a senior research scientist at GE Global Research and a principal technology consultant and head of data science at Attune Technologies. He has a B.S. and M.S. in Mathematics from the University of Madras, India, a Ph.D. in Applied Mathematics from the University of Florida and was a post-doctoral scholar at UCLA.
Vivek Vaidya is a senior principal scientist at Concerto HealthAI whose work enables powerful AI modeling and analytics solutions. In 2018, Silicon India magazine named him one of India's top 10 data scientists. At Concerto HealthAI, Vivek has been instrumental in driving four critical AI models (stage, survival, neutropenia and metastatic status) from clinical validation to industry application. Previously, he worked at GE Global Research where he led teams in building a deep learning accelerator platform, recently released as Edison AI. Vivek has filed 20 patents on a variety of technologies, including interactive representation transfer of deep learning ontologies, MRI scanner automation and distributed solutions for deep learning. He also has over 30 conference and journal publications on AI technologies and applications. Vivek has a B.S. in Computer Science from Washington State University.
About Concerto HealthAI Concerto HealthAI is a technology leader in Definitive Real-world Data (RWD) and AI solutions for precision health. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is to revolutionize clinical and outcomes research to accelerate the insights and outcomes benefiting patient treatment. Concerto HealthAI is a SymphonyAI company. eurekaHealth is a trademark of Concerto HealthAI. For more information, visit us at http://www.concertohealthai.com.
SOURCE Concerto HealthAI
